Download Policy PDF

It is the policy of New York University (NYU, “the University”) that all clinical trials shall be performed in accordance with generally accepted standards of good clinical practice, in compliance with the protocol and with all applicable local, state and Federal laws and regulations governing the performance of clinical investigations.

Purpose of this Policy


The purpose of this policy is to set forth the financial management requirements for Clinical Trials in accordance with Federal and sponsor requirements.

Scope of this Policy


This policy is applicable to all schools, departments, units and personnel of the University involved in administering sponsored awards.

Procedures for Implementation

Sponsored Programs Administration (SPA) Responsibilities:
  • Invoices – SPA will review all Clinical Trials invoices prepared by the school or department prior to submission to ensure compliance with sponsor terms and conditions.
  • Submission of Reports – SPA will follow-up and ensure the timely submission of interim and final financial reporting to Federal sponsors.
Department / Principal Investigator (PI) Responsibilities:
  • Clinical Trials Terms and Conditions – Upon receiving Institutional Animal Care and Use Committee (IACUC) and/or Institutional Review Board (IRB) approval and the fully executed agreement, the PI may start the Clinical Trial. The PI should abide by all clauses of the agreement. The PI is responsible for the performance of the scientific, technical, and administrative duties normally associated with the Clinical Trial. The PI is responsible for administering the trial in accordance with the signed agreement terms and conditions and the approved clinical research protocol as well as in compliance with University policies.
  • Budget Expenditures –The budget included in a clinical trial agreement is part of the agreement. PI’s should closely monitor the budget in the performance of the clinical trial.
  • Billing/Payments to Subjects –The department tracks milestones and performs timely billing of study activities for the appropriate Clinical Trial. The department must submit all invoices to SPA for review and approval prior to submission to the Sponsor. The department also coordinates appropriate and timely payments to participants.
  • Project Closeout – The PI and Department Administrator (DA) should ensure the submission of accurate and timely closeout documents to applicable Federal agencies, University entities, and the sponsor. The study documentation must be maintained in files in accordance with sponsor requirements and University policies and procedures.
  • Audits – The departments should notify SPA of any external audits associated with Clinical Trials. See the Internal and External Audits Policy for Sponsored Programs.

Download the Policy PDF

  1. Dates of official enactment and amendments: Dec 1, 2017
  2. History: last reviewed 12/31/2021
  3. Cross References: N/A